GlaxoSmithKline Pharmaceuticals Limited (GSK) announced the appointment of Omkar Parnandiwar as Head of Omnichannel, with effect from November 1, 2023. According to the company’s exchange filing, “we hereby inform you that the appointment of Mr. Omkar Parnandiwar, Head of Omnichannel effective 1st November, 2023. He will be part of the Senior Management team of the…
The Board of GSK has announced that Brian McNamara, the CEO of GSK Consumer Healthcare (a Joint Venture between GSK and Pfizer) has been appointed as CEO Designate of the new, listed Consumer Healthcare company which will result from the proposed demerger of Consumer Healthcare from GSK in 2022. Sir Jonathan Symonds, GSK Chairman, said,…
India’s largest FMCG company Hindustan Unilever Limited (HUL), recently announced that it has successfully completed the merger of GlaxoSmithKline Consumer Healthcare Limited (GSKCH) with HUL. This merger was first announced in December 2018 and was subject to obtaining necessary approvals. It is being said that the acquisition is one of the largest deals in the…
India’s fastest growing Contract Development and Manufacturing Organization (CDMOs) Sai Life Sciences recently announced the appointment of Dr. Dean Edney as Senior Vice President and Global Head of Process Research & Development. In a press release, the company said that Edney will split his time between the company’s R&D center in Hyderabad, India and the…
GlaxoSmithKline plc has reached an agreement with Pfizer Inc to combine their consumer health businesses into a new world-leading Joint Venture, with combined sales of approximately £9.8 billion ($12.7 billion). The JV will operate globally under the GSK Consumer Healthcare name. Under the terms of the transaction, GSK will have a majority controlling equity interest…
Fast-moving consumer goods major Hindustan Unilever announced an all-equity merger of itself with GlaxoSmithKline Consumer Healthcare Limited (GSK CH India), for a transaction worth Rs 31,700 crore in the country’s largest deal within consumer goods market. The all-equity merger deal includes an exchange ratio of 4.39 HUL shares for each GSK Consumer India share, along with…